| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 2 securities · passive | ||||||
|
Retension Pharmaceuticals, Inc.
13G
RTSN · 76135H100
|
10.0% |
10/16/2026
Event 10/13/2026
|
||||
| The B Group, Inc. | 10.0% | |||||
| B Group Capital LLC | 10.0% | |||||
| Branden B. Muhl | 10.0% | |||||
|
NRx Pharmaceuticals, Inc.
13G
NRXP · 629444209
|
12.6% |
8/21/2025
Event 8/18/2025
|
||||
| The B Group, Inc. | 12.6% | |||||
| B Group Capital LLC | 12.6% | |||||
| Branden B. Muhl | 12.6% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.